AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03446807 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Droxidopa
Description: Droxidopa in 100, 200, and 300mg capsules. Maximum dose to be used in this study is 600mg.
Study NCT03446807 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Oral Tablet
Description: Placebo capsules to match Droxidopa 100, 200, and 300mg capsules.
Study NCT05156268 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab will be administered intravenously (IV) at 200mg every 3 weeks.
Study NCT05156268 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olaparib
Description: Olaparib will be administered orally at 300 mg every 12 hours.
Study NCT05665790 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiotherapy
Description: radiotherapy
Study NCT05665790 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: palliative surgery
Description: palliative surgery
Study NCT05998135 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atovaquone
Description: Given PO
Study NCT05998135 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo biopsy
Study NCT05998135 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT
Study NCT05998135 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Paracentesis
Description: Undergo paracentesis
Study NCT05726890 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: bedtime intervention for early childhood insomnia
Description: The intervention focuses on providing parents with skills on how to modify and limit their sleep-related interactions with their infant at bedtime. These changes are expected to foster the infant's ability to fall asleep independently at bedtime. It is also expected that after 1-2 weeks, these changes would lead to self-soothing also during the night.
Study NCT05726890 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: bedtime and nighttime intervention for early childhood insomnia
Description: The intervention focuses on providing parents with skills on how to modify and limit their sleep-related interactions with their infant at bedtime and during the night. These changes are expected to foster the infant's ability to fall asleep independently at bedtime and to resume sleep independently during the night.
Study NCT04358159 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ventralex
Description: Repair of the hernia by a Ventralex patch in sublay position
Study NCT04358159 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Progrip
Description: Repair of the hernia by a Progrip mesh in onlay position
Study NCT03322813 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ExAblate 4000 - Type 2
Description: Using ExAblate Model 4000 Type-2 to temporarily disrupt the blood brain barrier in non-enhancing suspected infiltrating glioma undergoing resection
Study NCT05378295 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Fermentable oligosaccharide
Description: Supplementation period 12 weeks
Study NCT05378295 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Personalized fiber mixture
Description: Supplementation period 12 weeks
Study NCT05949528 — intervention group
Intervention type: OTHER
Intervention: no intervention
Description: no intervention
Study NCT06303362 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Elastic band excercise
Description: experimenatal group was given elastic band excercises along with stretching (pectoralis major, minor, trapezius, rhomboids and neck flexors) and conventional therapy. Sessions will be given 3 days in a week for a period of 4 weeks. The assessment was done at baseline, after 2 weeks and at the end of 4 weeks.
Study NCT06303362 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: strengthening with conventional physical therapy
Description: control group was given strengthening excercises and stretching (pectoralis major, minor, trapezius, rhomboids (Sessions will be given 3 days in a week for a period of 4 weeks. The assessment was done at baseline, after 2 weeks and at the end of 4 weeks.
Study NCT04806165 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Repeated Administration
Description: A discussion with the chatbot, including follow ups over the course of 2 weeks to encourage help seeking for their eating disorder.
Study NCT04806165 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Personalized Recommendation
Description: A discussion with the chatbot, including identifying a personalized recommendation for accessing help for their eating disorder.
Study NCT04806165 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing
Description: A discussion with the chatbot, including motivational interviewing techniques to help overcome barriers to seeking care for their eating disorder.
Study NCT04806165 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Core Modules Only
Description: A discussion with the chatbot, including only the core modules.
Study NCT04806165 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing, Personalized Recommendation, Repeated Administration
Description: A discussion with the chatbot, including motivational interviewing techniques to help overcome barriers to seeking care for their eating disorder, identifying a personalized recommendation for accessing help for their eating disorder, and follow ups over the course of 2 weeks to encourage help seeking for their eating disorder.
Study NCT04806165 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing, Repeated Administration
Description: A discussion with the chatbot, including motivational interviewing techniques to help overcome barriers to seeking care for their eating disorder and follow ups over the course of 2 weeks to encourage help seeking for their eating disorder.
Study NCT04806165 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing, Personalized Recommendation
Description: A discussion with the chatbot, including motivational interviewing techniques to help overcome barriers to seeking care for their eating disorder and identifying a personalized recommendation for accessing help for their eating disorder.
Study NCT04806165 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Personalized Recommendation, Repeated Administration
Description: A discussion with the chatbot, including identifying a personalized recommendation for accessing help for their eating disorder and follow ups over the course of 2 weeks to encourage help seeking for their eating disorder.
Study NCT04806165 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducation
Description: A discussion with the chatbot, including psychoeducational content to increase knowledge related to eating disorders.
Study NCT06210022 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Neuropsychological Assessment
Description: Cognitive evaluation and clinical monitoring of seizure frequency
Study NCT05538546 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Complete blood count
Description: Complete blood count will be conducted at 12th month and 24th month from baseline.
Study NCT05538546 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Transient elastrography
Description: Transient elastrography, and endoscopy will be conducted at 12th month and 24th month from baseline.
Study NCT05538546 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Endoscopy
Description: Endoscopy will be conducted at 12th month and 24th month from baseline.
Study NCT04515329 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclosporine
Description: Eye drops taken twice daily.
Study NCT04515329 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Artificial tear
Description: Preservative-free artificial tear drops 4 times a day.
Study NCT04515329 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Artificial tear
Description: Preservative-free artificial tear drops 4 times a day.
Study NCT05164146 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: propofol
Description: during the induction, remimazolam dose was controlled according to sedline (Psi target 40)
Study NCT05164146 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: remimazolam
Description: During induction, remimazolam dose was controlled according to sedline (Psi target 40)
Study NCT04806165 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducation, Repeated Administration
Description: A discussion with the chatbot, including psychoeducational content to increase knowledge related to eating disorders and follow ups over the course of 2 weeks to encourage help seeking for their eating disorder.
Study NCT04806165 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducation, Personalized Recommendation
Description: A discussion with the chatbot, including psychoeducational content to increase knowledge related to eating disorders and identifying a personalized recommendation for accessing help for their eating disorder.
Study NCT04806165 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducation, Motivational Interviewing
Description: A discussion with the chatbot, including psychoeducational content to increase knowledge related to eating disorders and motivational interviewing techniques to help overcome barriers to seeking care for their eating disorder.
Study NCT04806165 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducation, Motivational Interviewing, Personalized Recommendation
Description: A discussion with the chatbot, including psychoeducational content to increase knowledge related to eating disorders, motivational interviewing techniques to help overcome barriers to seeking care for their eating disorder, and identifying a personalized recommendation for accessing help for their eating disorder.
Study NCT04806165 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducation, Personalized Recommendation, Repeated Administration
Description: A discussion with the chatbot, including psychoeducational content to increase knowledge related to eating disorders, identifying a personalized recommendation for accessing help for their eating disorder, and follow ups over the course of 2 weeks to encourage help seeking for their eating disorder.
Study NCT04806165 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducation, Motivational Interviewing, Repeated Administration
Description: A discussion with the chatbot, including psychoeducational content to increase knowledge related to eating disorders, motivational interviewing techniques to help overcome barriers to seeking care for their eating disorder, and follow ups over the course of 2 weeks to encourage help seeking for their eating disorder.
Study NCT04806165 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducation, Motivational Interviewing, Personalized Recommendation, Repeated Administration
Description: A discussion with the chatbot, including psychoeducational content to increase knowledge related to eating disorders, motivational interviewing techniques to help overcome barriers to seeking care for their eating disorder, identifying a personalized recommendation for accessing help for their eating disorder, and follow ups over the course of 2 weeks to encourage help seeking for their eating disorder.
Study NCT05416385 — intervention group
Intervention type: OTHER
Intervention: Carotid Contrast Enhanced Ultrasound
Description: Carotid Contrast-Enhanced Ultrasound (CEUS), a diagnostic ultrasound enhancing agent that opacifies the blood to delineate the vessel walls.
Study NCT05020496 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Diphenylcyclopropenone (DPCP)
Description: Drug will be applied topically on the skin. It will cause contact hypersensitivity in patients
Study NCT05020496 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diphenylcyclopropenone (DPCP)
Description: Drug will be applied topically on the skin. It will cause contact hypersensitivity in patients
Study NCT05326594 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Mckenzie Extension Protocol
Description: Mckenzie Extension Exercise Protocol will be performed by participants in prone position
Study NCT05326594 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Lumbar SNAGs
Description: Lumbar SNAGs will be performed in lumbar flexion and extension in standing Position
Study NCT05326594 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Inferential therapy
Description: 4 pole inferential therapy in combination with superficial heating for 20 minutes
Study NCT05326594 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Heat Therapy
Description: superficial heating for 20 minutes
Study NCT04890028 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: F-DOPA PET/CT
Description: All subjects will be imaged~1 time injection of 2 MBq/kg of 18F-DOPA
Study NCT05872581 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hand scanner instant feedback
Description: Participants will be informed about their hand scanner results of the first hand washing attempt to get individualized feedback about their hand wash performance.
Study NCT05872581 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Video training
Description: Participants will watch a training video about the 7 steps of hand washing after the first hand washing attempt.
Study NCT05185167 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anesthetics, General Desflurane Maintenance
Description: Comparison of dna damage of desflurane maintenance with propofol maintenance according to comet analysis
Study NCT05185167 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anesthetics, General Propofol Maintenance
Description: Comparison of dna damage of propofol maintenance with desflurane maintenance according to comet analysis
Study NCT05389865 — intervention group
Intervention type: PROCEDURE
Intervention: Surgery on the proximal aorta (aortic root +/- ascending aorta)
Description: Surgery involving replacing, repairing or reinforcing the proximal aorta (root and ascending aorta)
Study NCT05389865 — intervention group
Intervention type: OTHER
Intervention: Patients diagnosed with thoracic aortopathy but not operated upon
Description: Radiological size criteria or Genetic mutations associated with aortopathies
Study NCT05910489 — intervention group
Intervention type: OTHER
Intervention: Biomonitoring of MNPLs in biological samples of greenhouse workers and controls
Description: Detection of biomarkers of exposure and genotoxic effect in biological blood, urine, exhalated air condensate, and feces
Study NCT06281197 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Conventional
Description: Le Fort I osteotomy performed with conventional Le Fort
Study NCT06281197 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Subspinal
Description: Osteotomy was performed in the subspinal Le Fort I group that is described by Mommaerts
Study NCT05935202 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitapivat sulfate
Description: Subjects enrolled Maximum dose: will receive Mitapivat during 56 weeks Starting dose: 50 mg BD Maximum dose: 100 mg BD
Study NCT06035978 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nebivolol
Description: Nebivolol (Nebilet) tablet will be administered orally to patients according to their clinical condition and the decision of the attending physician.
Study NCT06035978 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Valsartan and Sacubitril
Description: Valsartan and Sacubitril (Entresto) tablet will be administered orally to patients according to their clinical condition and the decision of the attending physician.
Study NCT06035978 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carvedilol
Description: Carvedilol (Dilatrend) tablet will be administered orally to patients according to their clinical condition and the decision of the attending physician.
Study NCT06035978 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bisoprolol
Description: Bisoprolol (Concor) tablet will be administered orally to patients according to their clinical condition and the decision of the attending physician.
Study NCT06035978 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metoprolol
Description: Metoprolol (Betaloc ZOK) tablet will be administered orally to patients according to their clinical condition and the decision of the attending physician.
Study NCT06035978 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Spironolactone
Description: Verospiron (Spironolactone) tablet will be administered orally to patients according to their clinical condition and the decision of the attending physician.
Study NCT06498609 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: iprf
Description: i-PRF with leveling and alignment
Study NCT03150732 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Systemic nalbuphine
Description: Patients will receive systemic nalbuphine 10 mg
Study NCT06498609 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: MOPs with leveling and alignment
Description: mop
Study NCT04658888 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Evalyn Self-Sampling Brush
Description: A self-sampling brush to collect cervical cancer cells for screening purposes.
Study NCT06358599 — intervention group
Intervention type: DRUG
Intervention: Cisplatin
Description: Neoadjuvant cisplatin-containing combination chemotherapy was defined as the receipt of multiagent systemic chemotherapy initiated within 6 months prior to the date of radical cystectomy
Study NCT06196372 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MenoMind intervention group
Description: To implement the MenoMind program, the women in the initiative group were divided into groups of 4-5 according to their convenient days and hours, and it was done via the Zoom© program. MenoMind program was carried out via video on WhatsApp© program for women who could not or did not want to use the Zoom© program. The researcher provided support to the women for eight weeks, in different groups, 2-3 days a week and at different times, depending on their availability. Each session is approximately 50 minutes. lasted. In addition, make-up sessions were organized for women who could not attend the sessions for various reasons or had difficulty complying with the program (day/date).
Study NCT06358261 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Diabetes Prevention Patient Activation Clinical Decision Support Tool
Description: Diabetes Prevention Patient Activation Clinical Decision Support Tool will be used by the doctor during the visit to discuss lifestyle management
Study NCT05230992 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cryoprobes First
Description: In this experimental group, the Cryoprobe is used in first and the classic biopsy forceps in a second time. This medical device under study is the flexible, single-use Cryoprobe, supplied in sterile condition, 1.1 mm in diameter, 1150 mm long, with extraction tube, 817 mm long (reference 20402-401), or 757 mm long (reference 20402-402) marketed. These cryoprobes are covered by a CE marking. Cryoprobes must be used in conjunction with the Erbecryo®2 device and its accessories.
Study NCT05230992 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cryoprobes Second
Description: In this second experimental group, the same medical devices are used but in the other order.
Study NCT03150732 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Local nalbuphine
Description: Patients will receive local nalbuphine 10 mg
Study NCT05832866 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinical Based Isometric contraction strengthening Exercises using Thera band
Description: Patients did isometric contraction exercises using thera band in the clinic physically. They did not need to be monitored by telephone
Study NCT06115811 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Radiation Treatment Plan Evaluation Learning Tool
Description: Web-based program comprised of a systematic, oncology treatment plan review system and learning modules. The case bank of radiation treatments plans is accessible via econtour.org.
Study NCT04168879 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine 0.5% Preservative-Free Injectable Solution
Description: 1.5 ml of Bupivacaine 0.5% Preservative-Free Injectable Solution used to block the sphenopalatine ganglion by ultrasound guided suprazygomatic approach
Study NCT04168879 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: normal saline
Description: 1.5 ml of normal saline is delivered to the sphenopalatine ganglion by ultrasound guided suprazygomatic approach
Study NCT06113575 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NeuroStar TMS
Description: NeuroStar TMS treatment - 90-120% of Observed MT, 3 pulses/burst, 5 bursts/sec, 2 sec stimulation, 20 msec interval, 20 trains, 600 total pulses/session for 36 treatments in 5 days. 6 treatments on day 1, 8 treatments on days 2, 3, and 4, 6 treatments on day 5.
Study NCT05855031 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Transient Elastography
Description: One transient elastography 1-2 weeks after randomization
Study NCT05826886 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Emotional Writing
Description: Participants complete four 20-minute sessions of emotional writing (at home) on four consecutive days. Instructions are provided online before each writing session.